239 related articles for article (PubMed ID: 24140401)
1. Psychoactive substances--some new, some old: a scan of the situation in the U.S.
Maxwell JC
Drug Alcohol Depend; 2014 Jan; 134():71-77. PubMed ID: 24140401
[TBL] [Abstract][Full Text] [Related]
2. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
3. The Changing Face of Synthetic Cannabinoids in Texas.
Maxwell JC
J Psychoactive Drugs; 2018; 50(4):281-286. PubMed ID: 30321129
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.
Palamar JJ; Su MK; Hoffman RS
Am J Drug Alcohol Abuse; 2016; 42(1):39-47. PubMed ID: 26678258
[TBL] [Abstract][Full Text] [Related]
5. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.
Spiller HA; Ryan ML; Weston RG; Jansen J
Clin Toxicol (Phila); 2011 Jul; 49(6):499-505. PubMed ID: 21824061
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
[TBL] [Abstract][Full Text] [Related]
8. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
[TBL] [Abstract][Full Text] [Related]
9. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
[TBL] [Abstract][Full Text] [Related]
10. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
11. Synthetic cathinone exposures reported to Texas poison centers.
Forrester MB
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):609-15. PubMed ID: 22541001
[TBL] [Abstract][Full Text] [Related]
12. Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.
Palamar JJ; Le A
Hum Psychopharmacol; 2019 Mar; 34(2):e2690. PubMed ID: 30843283
[TBL] [Abstract][Full Text] [Related]
13. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB; Haywood T
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
[TBL] [Abstract][Full Text] [Related]
14. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
[TBL] [Abstract][Full Text] [Related]
15. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
[TBL] [Abstract][Full Text] [Related]
16. Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey.
Simonato P; Corazza O; Santonastaso P; Corkery J; Deluca P; Davey Z; Blaszko U; Schifano F
Hum Psychopharmacol; 2013 Jul; 28(4):324-31. PubMed ID: 23881880
[TBL] [Abstract][Full Text] [Related]
17. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
[TBL] [Abstract][Full Text] [Related]
18. Consumption of new psychoactive substances in a Spanish sample of research chemical users.
González D; Ventura M; Caudevilla F; Torrens M; Farre M
Hum Psychopharmacol; 2013 Jul; 28(4):332-40. PubMed ID: 23881881
[TBL] [Abstract][Full Text] [Related]
19. Assessing self-reported use of new psychoactive substances: The impact of gate questions.
Palamar JJ; Acosta P; Calderón FF; Sherman S; Cleland CM
Am J Drug Alcohol Abuse; 2017 Sep; 43(5):609-617. PubMed ID: 28485987
[TBL] [Abstract][Full Text] [Related]
20. Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.
Palamar JJ; Barratt MJ; Ferris JA; Winstock AR
Am J Addict; 2016 Aug; 25(5):400-7. PubMed ID: 27419383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
